Literature DB >> 16499771

The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year.

Elisabeth B Marsh1, John M Freeman, Eric H Kossoff, Eileen P G Vining, James E Rubenstein, Paula L Pyzik, Cheryl Hemingway.   

Abstract

PURPOSE: To determine the long-term outcome of children with difficult-to-control seizures who remained on the ketogenic diet for <1 year.
METHODS: Between 1994 and 1996, 150 children with epilepsy, refractory to at least two medications, initiated the ketogenic diet according to the Hopkins protocol. Three to six years after diet initiation, all the families were contacted by telephone or questionnaire to assess their child's current seizure status, medications, and therapies.
RESULTS: Sixty-seven children discontinued the diet within 1 year of initiation. Follow-up data were available for 54 of these children. Ten subsequently had surgery, and three underwent VNS implantation. These operated-on children were significantly more likely to be >50% controlled at follow-up than were those managed with medications alone (p < 0.05). A statistically significant difference in long-term outcome was noted between those who responded while on the diet, even if they discontinued it before 1 year, and those who did not (p < 0.05), but no statistical correlation was found between length of time that they had remained on the diet and long-term prognosis.
CONCLUSIONS: Almost half of the children who discontinued the diet during the first year had a decrease in seizures when assessed 3-6 years later. Twenty-two percent of these had become seizure free without surgery. We were unable to ascertain whether this may have been due to new medications. Those who saw some improvement while on the diet were more likely to have a favorable long-term outcome. Resective surgery, in children who were candidates, or vagal nerve stimulation (VNS) implantation, was more likely to result in significant seizure improvement than was management with medications alone. Whether or not the diet was effective, most families did not regret trying it and would recommend it to others.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499771     DOI: 10.1111/j.1528-1167.2006.00439.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

Review 2.  Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Authors:  Sharon S McDaniel; Michael Wong
Journal:  Neurosci Lett       Date:  2011-02-24       Impact factor: 3.046

3.  The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway.

Authors:  Sharon S McDaniel; Nicholas R Rensing; Liu Lin Thio; Kelvin A Yamada; Michael Wong
Journal:  Epilepsia       Date:  2011-03-03       Impact factor: 5.864

Review 4.  Does Neuroinflammation Underlie the Cognitive Changes Observed With Dietary Interventions?

Authors:  Jacqueline P Robbins; Egle Solito
Journal:  Front Neurosci       Date:  2022-05-10       Impact factor: 5.152

5.  The ketogenic diet: uses in epilepsy and other neurologic illnesses.

Authors:  Kristin W Barañano; Adam L Hartman
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

Review 6.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 7.  The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.

Authors:  Marwan Maalouf; Jong M Rho; Mark P Mattson
Journal:  Brain Res Rev       Date:  2008-09-25

Review 8.  Ketogenic diets: evidence for short- and long-term efficacy.

Authors:  Eric H Kossoff; Jong M Rho
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 9.  Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy.

Authors:  Samantha L Hodges; Joaquin N Lugo
Journal:  Epilepsy Res       Date:  2020-01-30       Impact factor: 2.991

Review 10.  Therapeutic Success of the Ketogenic Diet as a Treatment Option for Epilepsy: a Meta-analysis.

Authors:  Hai-Feng Li; Yan Zou; Gangqiang Ding
Journal:  Iran J Pediatr       Date:  2013-12       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.